Nanodiagnostics to Face SARS-CoV-2 and Future Pandemics: From an Idea to the Market and beyond

Página do item simplificado
dc.contributor.authorRosati G.
dc.contributor.authorIdili A.
dc.contributor.authorParolo C.
dc.contributor.authorFuentes-Chust C.
dc.contributor.authorCalucho E.
dc.contributor.authorHu L.
dc.contributor.authorCastro E Silva C.D.C.
dc.contributor.authorRivas L.
dc.contributor.authorNguyen E.P.
dc.contributor.authorBergua J.F.
dc.contributor.authorAlvarez-Diduk R.
dc.contributor.authorMunoz J.
dc.contributor.authorJunot C.
dc.contributor.authorPenon O.
dc.contributor.authorMonferrer D.
dc.contributor.authorDelamarche E.
dc.contributor.authorMerkoci A.
dc.date.accessioned2024-03-12T19:18:35Z
dc.date.available2024-03-12T19:18:35Z
dc.date.issued2021
dc.description.abstract© The COVID-19 pandemic made clear how our society requires quickly available tools to address emerging healthcare issues. Diagnostic assays and devices are used every day to screen for COVID-19 positive patients, with the aim to decide the appropriate treatment and containment measures. In this context, we would have expected to see the use of the most recent diagnostic technologies worldwide, including the advanced ones such as nano-biosensors capable to provide faster, more sensitive, cheaper, and high-throughput results than the standard polymerase chain reaction and lateral flow assays. Here we discuss why that has not been the case and why all the exciting diagnostic strategies published on a daily basis in peer-reviewed journals are not yet successful in reaching the market and being implemented in the clinical practice.
dc.description.firstpage17137
dc.description.issuenumber11
dc.description.lastpage17149
dc.description.volume15
dc.identifier.doi10.1021/acsnano.1c06839
dc.identifier.issn1936-0851
dc.identifier.urihttps://dspace.mackenzie.br/handle/10899/34558
dc.relation.ispartofACS Nano
dc.rightsAcesso Aberto
dc.subject.otherlanguagebiosensors
dc.subject.otherlanguagebottlenecks
dc.subject.otherlanguageCOVID-19
dc.subject.otherlanguagenanodiagnostics
dc.subject.otherlanguageoutbreaks
dc.subject.otherlanguagephases of test development
dc.subject.otherlanguageSARS-CoV-2
dc.subject.otherlanguagetesting methods
dc.titleNanodiagnostics to Face SARS-CoV-2 and Future Pandemics: From an Idea to the Market and beyond
dc.typeArtigo de revisão
local.scopus.citations35
local.scopus.eid2-s2.0-85118930117
local.scopus.subjectBottleneck
local.scopus.subjectCOVID-19
local.scopus.subjectDiagnostic assays
local.scopus.subjectDiagnostic device
local.scopus.subjectNanodiagnostic
local.scopus.subjectOutbreak
local.scopus.subjectPhase of test development
local.scopus.subjectSARS-CoV-2
local.scopus.subjectTest development
local.scopus.subjectTesting method
local.scopus.subjectCOVID-19
local.scopus.subjectCOVID-19 Testing
local.scopus.subjectHumans
local.scopus.subjectPandemics
local.scopus.subjectSARS-CoV-2
local.scopus.updated2024-12-01
local.scopus.urlhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85118930117&origin=inward
Arquivos
Coleções
Artigos de periódico